Работы, цитирующие эту работу

Работ: 5

Работа: Successful ‘9-month Bangladesh regimen’ for multidrug-resistant tuberculosis among over 500 consecutive patients

1. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Обзорная статьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2017Цитирований: 4

   ABIABI:AkademIndex/openalex/2017.review-article.000004

2. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   СтатьяTuberculosis Research and EpidemiologyBMC Medicine2016Цитирований: 3

   ABIABI:AkademIndex/openalex/2026.other.195695

3. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

   S.K. Abidi, Jay Achar, M.M. Assao Neino +34

   СтатьяTuberculosis Research and EpidemiologyEuropean Respiratory Journal2019Цитирований: 1

   ABIABI:AkademIndex/openalex/2019.article.000020

4. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis

   Aleksandr Trubnikov, Arax Hovhannesyan, Kristina Akopyan +5

   СтатьяTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health2021Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.262608

5. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen

   Jay Achar, Catherine Berry, Krzysztof Herboczek +7

   ДругоеTuberculosis Research and EpidemiologyEmerging infectious diseases2015Цитирований: 0

   ABIABI:AkademIndex/openalex/2015.other.000001